She suffered from Sjogren syndrome and inflammatory arthritis and was currently treated with prednisone and methotrexate. She was previously treated with hydroxychloroquine (Plaquenil) 200mg bid (6.5mg/kg) for 10 years, which was stopped one year prior to presentation. Plaquenil side effects on liver Hydroxychloroquine 400 mg side effects Is plaquenil safe to take Apr 26, 2019 How to set up a Hydroxychloroquine Retinopathy Screening Service. Shah CP, et al. Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes. Taking hydroxychloroquine. If you are already on the screening programme for hydroxychloroquine retinopathy, and your last screening tests were normal, it is very unlikely that your symptoms are due to hydroxychloroquine retinopathy. The next screening visit does not need to happen sooner than planned. However, Screening for hydroxychloroquine retinopathy. The aim of screening is not to prevent retinopathy but to detect the earliest definitive signs of the. condition, before a patient notices any symptoms. The risk of getting hydroxychloroquine retinopathy. is negligible unless you have been taking the drug Review of systems: Blurred vision, halos, dry eye, dry mouth, gastroesophageal reflux, joint pain Pupils: Reactive to light in each eye from 5 mm in the dark to 2 mm in the light. Extraocular movements: Full, both eyes (OU) Confrontation visual fields: Full OU Intra-ocular pressure The optic nerves appeared healthy with a 0.3 cup-to-disc ratio. Past Ocular History: None Medical History: Sjogren syndrome and inflammatory arthritis, supraventricular tachycardia, anxiety, depression, peptic ulcer disease Medications: prednisone, methotrexate, amitriptyline, ranitidine, estradiol, tizanidine, diltiazem, Restasis Allergies: codeine, droperidol Family History: heart disease, arthritis, cancer Social History: occasional alcohol but no tobacco or intravenous drug use. Hydroxychloroquine retinopathy screening Hydroxychloroquine Retinopathy Still Alive and Well - The Rheumatologist, Eye screening for patients taking hydroxychloroquine Plaquenil Hydroxychloroquine other usesPlaquenil a preventive medicine Of retinopathy, as a result of long term use of hydroxychloroquine. Evidence suggests the prevalence of hydroxychloroquine retinopathy has been underestimated and recommends a hospital based screening programme for patients to provide assurance that current treatment regimens are within safe parameters. Hydroxychloroquine and Retinal Screening. Eye screening for patients taking hydroxychloroquine.. Hydroxychloroquine retinopathy A review of imaging. How to set up a Hydroxychloroquine Retinopathy Screening Service. Shah CP, et al. Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes. Hydroxychloroquine Plaquenil and chloroquine cause ocular toxicity to various parts of the eye such as the cornea, ciliary body, and retina. Chloroquine can also induce cataract formation; however, no reports of hydroxychloroquine and cataract have been reported. This article focuses upon hydroxychloroquine retinopathy. Disease The recommended dose for hydroxychloroquine is 6.5 mg/kg lean body weight per day.4 In their prospective study of 73 patients treated with hydroxychloroquine for at least 18 months, Morsman et al reported one case of possible toxic retinopathy—and this patient had received twice the recommended daily dose.5 In a retrospective study of 82.